An Immunogenic Cell Death-Related Gene Signature Predicts the Prognosis and Immune Infiltration of Cervical Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study developed an immunogenic cell death (ICD) gene signature to predict cervical cancer (CC) prognosis and immune infiltration. The signature effectively stratified patients, offering new insights for CC diagnosis and treatment.
Area Of Science
- Oncology
- Immunology
- Genomics
Background
- Immunogenic cell death (ICD) influences anti-tumor immunity in many cancers.
- The role of ICD in cervical cancer (CC) prognosis and immune microenvironment is not well understood.
Purpose Of The Study
- To develop an ICD-related gene signature for predicting prognosis and immune cell infiltration in cervical cancer.
- To explore the potential of ICD in CC diagnosis and treatment strategies.
Main Methods
- Utilized The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets for CC gene expression and clinical data.
- Employed the LASSO-Cox model to construct a 3-gene ICD signature (IL1B, IFNG, FOXP3).
- Validated gene expression in CC cell lines and clinical samples.
Main Results
- Identified two ICD-associated subtypes, with cluster 2 showing higher immune infiltration and better prognosis.
- The 3-gene ICD signature independently predicted CC prognosis and influenced immune cell abundance.
- Validated the up-regulation of IL1B, IFNG, and FOXP3 in CC.
Conclusions
- ICD-related gene stratification effectively predicts CC patient prognosis and immune cell infiltration.
- This approach offers valuable new perspectives for CC diagnosis and prognosis.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.